Pictet North America Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,275
| Closed | -$202K | – | 147 |
|
|
2024
Q1 | $202K | Hold |
7,275
| – | – | 0.02% | 141 |
|
|
2023
Q4 | $209K | Sell |
7,275
-400
| -5% | -$12.1K | 0.03% | 126 |
|
|
2023
Q3 | $255K | Sell |
7,675
-3,000
| -28% | -$106K | 0.04% | 120 |
|
|
2023
Q2 | $392K | Sell |
10,675
-1,200
| -10% | -$46.7K | 0.05% | 106 |
|
|
2023
Q1 | $485K | Hold |
11,875
| – | – | 0.08% | 96 |
|
|
2022
Q4 | $608K | Hold |
11,875
| – | – | 0.1% | 92 |
|
|
2022
Q3 | $520K | Buy |
11,875
+3,400
| +40% | +$165K | 0.08% | 105 |
|
|
2022
Q2 | $444K | Hold |
8,475
| – | – | 0.06% | 110 |
|
|
2022
Q1 | $439K | Hold |
8,475
| – | – | 0.05% | 103 |
|
|
2021
Q4 | $500K | Buy |
8,475
+1,200
| +16% | +$59.5K | 0.05% | 98 |
|
|
2021
Q3 | $313K | Hold |
7,275
| – | – | 0.03% | 107 |
|
|
2021
Q2 | $285K | Hold |
7,275
| – | – | 0.03% | 114 |
|
|
2021
Q1 | $264K | Sell |
7,275
-23,377
| -76% | -$830K | 0.03% | 114 |
|
|
2020
Q4 | $1.13M | Sell |
30,652
-1,655
| -5% | -$60.7K | 0.14% | 72 |
|
|
2020
Q3 | $1.13M | Hold |
32,307
| – | – | 0.16% | 70 |
|
|
2020
Q2 | $1M | Buy |
32,307
+23,188
| +254% | +$788K | 0.14% | 77 |
|
|
2020
Q1 | $282K | Sell |
9,119
-8,762
| -49% | -$299K | 0.05% | 121 |
|
|
2019
Q4 | $665K | Hold |
17,881
| – | – | 0.08% | 102 |
|
|
2019
Q3 | $610K | Sell |
17,881
-1,265
| -7% | -$46K | 0.08% | 104 |
|
|
2019
Q2 | $787K | Sell |
19,146
-81
| -0.4% | -$3.22K | 0.11% | 91 |
|
|
2019
Q1 | $775K | Buy |
19,227
+81
| +0.4% | +$3.24K | 0.12% | 93 |
|
|
2018
Q4 | $793K | Hold |
19,146
| – | – | 0.07% | 97 |
|
|
2018
Q3 | $801K | Buy |
19,146
+7,668
| +67% | +$295K | 0.11% | 97 |
|
|
2018
Q2 | $395K | Hold |
11,478
| – | – | 0.06% | 108 |
|
|
2018
Q1 | $386K | Hold |
11,478
| – | – | 0.06% | 105 |
|
|
2017
Q4 | $394K | Buy |
11,478
+2,737
| +31% | +$93.3K | 0.06% | 103 |
|
|
2017
Q3 | $296K | Hold |
8,741
| – | – | 0.05% | 116 |
|
|
2017
Q2 | $279K | Hold |
8,741
| – | – | 0.05% | 114 |
|
|
2017
Q1 | $284K | Hold |
8,741
| – | – | 0.05% | 111 |
|
|
2016
Q4 | $269K | Hold |
8,741
| – | – | 0.06% | 93 |
|
|
2016
Q3 | $281K | Sell |
8,741
-3,512
| -29% | -$117K | 0.07% | 84 |
|
|
2016
Q2 | $409K | Buy |
12,253
+3,512
| +40% | +$112K | 0.1% | 84 |
|
|
2016
Q1 | $246K | Buy |
+8,741
| New | +$250K | 0.05% | 83 |
|
Other funds holding PFE
Pictet North America Advisors's PFE Position: Q2 2024 in Review
Pictet North America Advisors sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,275 shares — an estimated $202K sold.
Pictet North America Advisors first reported a position in PFE in Q1 2016 and held it in 33 quarters. The position peaked at $1.13M in Q4 2020. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Pictet North America Advisors reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- Pictet North America Advisors sold 7,275 Pfizer shares in Q2 2024, an estimated $202K.
- Pictet North America Advisors first reported a position in Pfizer in Q1 2016 and held it in 33 quarters.
- Pictet North America Advisors's Pfizer position peaked at $1.13M in Q4 2020.
- 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Pictet North America Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.